Abstract
Background/Objectives
Studies examining the association between coffee consumption and metabolic syndrome (MetS), considering different coffee types, have reported inconsistent results. We investigated the relationship between coffee consumption and MetS, taking into account coffee types, using data from the Korea National Health and Nutrition Examination Survey conducted from 2016 to 2021 among 14,631 adults aged 19–64 years.
Subjects/Methods
We used a 24-h dietary recall method to assess diet, including the type and quantity of coffee consumed. Coffee was categorized into black coffee and coffee with sugar and/or cream (non-drinkers, ≤1, 2–3, and >3 cups/day). Multivariable logistic regression models were utilized to investigate the relationship between coffee consumption and MetS, defined by the harmonized criteria.
Results
After adjusting for potential covariates, for women, 2–3 cups/day of black coffee were inversely associated with MetS (OR = 0.66; 95% CI = 0.46–0.96). Three or fewer cups per day of black coffee were inversely associated with low high-density lipoprotein cholesterol (HDL-C) and elevated triglycerides in women. Coffee consumption was not significantly associated with MetS in men. Consumption of coffee with sugar and/or cream or more than three cups per day of coffee was not significantly associated with MetS overall.
Conclusion
Our findings suggest that moderate of 2–3 cups/day of black coffee consumption is inversely associated with MetS in women, possibly due to its favorable impact on HDL-C and triglycerides. Further prospective studies examining the consumption of different coffee types in relation to MetS are warranted to offer definitive evidence.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The relevant data are publicly available through KNHANES website: https://knhanes.kdca.go.kr/knhanes/eng/index.do.
References
Silveira Rossi JL, Barbalho SM, Reverete de Araujo R, Bechara MD, Sloan KP, Sloan LA. Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors. Diabetes Metab Res Rev. 2022;38:e3502.
Hudish LI, Reusch JE, Sussel L. β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes. J Clin Investig. 2019;129:4001–8.
Battelli MG, Bortolotti M, Polito L, Bolognesi A. Metabolic syndrome and cancer risk: The role of xanthine oxidoreductase. Redox Biol. 2019;21:101070.
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–28.
Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018;20:12.
Finicelli M, Squillaro T, Di Cristo F, Di Salle A, Melone MAB, Galderisi U, et al. Metabolic syndrome, Mediterranean diet, and polyphenols: Evidence and perspectives. J Cell Physiol. 2019;234:5807–26.
Zhao W, Ma L, Cai C, Gong X. Caffeine Inhibits NLRP3 Inflammasome Activation by Suppressing MAPK/NF-κB and A2aR Signaling in LPS-Induced THP-1 Macrophages. Int J Biol Sci. 2019;15:1571–81.
Agunloye OM, Oboh G, Ademiluyi AO, Ademosun AO, Akindahunsi AA, Oyagbemi AA, et al. Cardio-protective and antioxidant properties of caffeic acid and chlorogenic acid: Mechanistic role of angiotensin converting enzyme, cholinesterase and arginase activities in cyclosporine induced hypertensive rats. Biomed Pharmacother. 2019;109:450–8.
Spagnol CM, Assis RP, Brunetti IL, Isaac VLB, Salgado HRN, Corrêa MA. In vitro methods to determine the antioxidant activity of caffeic acid. Spectrochimica Acta Part A Mol Biomolecular Spectrosc. 2019;219:358–66.
Kim J-Y, Leem J, Kim GM. Kahweol protects against acetaminophen-induced hepatotoxicity in mice through inhibiting oxidative stress, hepatocyte death, and inflammation. BioMed Res Int. 2022;2022:8121124.
Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2014;129:643–59.
Kim Y, Je Y, Giovannucci E. Coffee consumption and all-cause and cause-specific mortality: a meta-analysis by potential modifiers. Eur J Epidemiol. 2019;34:731–52.
Shang F, Li X, Jiang X. Coffee consumption and risk of the metabolic syndrome: A meta-analysis. Diabetes Metab. 2016;42:80–7.
Grosso G, Stepaniak U, Micek A, Topor-Mądry R, Pikhart H, Szafraniec K, et al. Association of daily coffee and tea consumption and metabolic syndrome: results from the Polish arm of the HAPIEE study. Eur J Nutr. 2015;54:1129–37.
Barrea L, Pugliese G, Frias-Toral E, El Ghoch M, Castellucci B, Chapela SP, et al. Coffee consumption, health benefits and side effects: a narrative review and update for dietitians and nutritionists. Crit Rev food Sci Nutr. 2023;63:1238–61.
Han G. Status of Beverage and Water Intake among Adults in Korea-Data from Korea National Health and Nutrition Examination Survey 2019. Korean J Food Nutr. 2021;34:430–40.
Corbi-Cobo-Losey MJ, Martinez-Gonzalez MÁ, Gribble AK, Fernandez-Montero A, Navarro AM, Domínguez LJ, et al. Coffee Consumption and the Risk of Metabolic Syndrome in the ‘Seguimiento Universidad de Navarra’Project. Antioxidants. 2023;12:686.
Kim HJ, Cho S, Jacobs DR Jr, Park K. Instant coffee consumption may be associated with higher risk of metabolic syndrome in Korean adults. Diabetes Res Clin Pract. 2014;106:145–53.
Kim S-A, Shin S. The association between coffee consumption pattern and prevalence of metabolic syndrome in Korean adults. Nutrients. 2019;11:2992.
Nina R, Lingling H, Qiushuang L, Honglin G, Liyuan S, Yuting Z. Association of coffee consumption pattern and metabolic syndrome among middle-aged and older adults: A cross-sectional study. Front Public Health. 2023;11:1022616.
Tan L-J, Jeon HJ, Park S, Kim S-A, Lim K, Chung S, et al. Association of coffee consumption and its types according to addition of sugar and creamer with metabolic syndrome incidence in a korean population from the health examinees (Hexa) study. Nutrients. 2021;13:920.
Kim Y, Je Y. Moderate coffee consumption is inversely associated with the metabolic syndrome in the Korean adult population. Br J Nutr. 2018;120:1279–87.
Kim K, Kim K, Park SM. Association between the prevalence of metabolic syndrome and the level of coffee consumption among Korean women. PLoS One. 2016;11:e0167007.
Kim J-H, Park YS, Kim H. Association between metabolic syndrome and coffee consumption in the Korean population by gender: a cross-sectional study in Korea. Asia Pac J Clin Nutr. 2018;27:1131–40.
Shin H, Linton JA, Kwon Y, Jung Y, Oh B, Oh S. Relationship between coffee consumption and metabolic syndrome in Korean adults: data from the 2013–2014 Korea National Health and Nutrition Examination Survey. Korean J Fam Med. 2017;38:346.
Shin S, Lim J, Lee H-W, Kim CE, Kim S-A, Lee J-k, et al. Association between the prevalence of metabolic syndrome and coffee consumption among Korean adults: results from the Health Examinees study. Appl Physiol Nutr Metab. 2019;44:1371–8.
Choi S, Je Y. Association between coffee consumption and high C-reactive protein levels in Korean adults. Brit J Nutr. 2023;130:2146–54.
Je Y, Jeong S, Park T. Coffee consumption patterns in Korean adults: the Korean National Health and Nutrition Examination Survey (2001-2011). Asia Pac J Clin Nutr. 2014;23:691–702.
Kweon S, Kim Y, Jang MJ, Kim Y, Kim K, Choi S, et al. Data resource profile: the Korea National Health and Nutrition Examination Survey (KNHANES). Int J Epidemiol. 2014;43:69–77.
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120:1640–5.
Lim J, Lee Y, Shin S, Lee HW, Kim CE, Lee JK, et al. An association between diet quality index for Koreans (DQI-K) and total mortality in Health Examinees Gem (HEXA-G) study. Nutr Res Pract. 2018;12:258–64.
Coffee and Metabolic Syndrome: A review of the latest research. Dublin, Ireland: Institute for scientific information on coffee; 2019.
Chang HC, Nfor ON, Ho CC, Chen PH, Kung YY, Hsu SY, et al. Changes in High-Density Lipoprotein Cholesterol Levels in Relation to Coffee Consumption Among Taiwanese Adults. J Multidiscip Health. 2020;13:1427–32.
Hsu TW, Tantoh DM, Lee KJ, Ndi ON, Lin LY, Chou MC, et al. Genetic and Non-Genetic Factor-Adjusted Association between Coffee Drinking and High-Density Lipoprotein Cholesterol in Taiwanese Adults: Stratification by Sex. Nutrients. 2019;11:1102.
Basu D, Goldberg IJ. Regulation of lipoprotein lipase-mediated lipolysis of triglycerides. Curr Opin Lipido. 2020;31:154–60.
Geidl-Flueck B, Hochuli M, Németh Á, Eberl A, Derron N, Köfeler HC, et al. Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial. J Hepatol. 2021;75:46–54.
Matsuura H, Mure K, Nishio N, Kitano N, Nagai N, Takeshita T. Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. J Epidemiol. 2012;22:160–6.
Kiyama R. Estrogenic activity of coffee constituents. Nutrients. 2019;11:1401.
Kremer JI, Gömpel K, Bakuradze T, Eisenbrand G, Richling E. Urinary excretion of niacin metabolites in humans after coffee consumption. Mol Nutr food Res. 2018;62:1700735.
Santolla MF, De Francesco EM, Lappano R, Rosano C, Abonante S, Maggiolini M. Niacin activates the G protein estrogen receptor (GPER)-mediated signalling. Cell Signal. 2014;26:1466–75.
Dos Santos PR, Ferrari GSL, Ferrari CK. Diet, sleep and metabolic syndrome among a legal Amazon population, Brazil. Clin Nutr Res. 2015;4:41–5.
Mesas AE, Leon-Muñoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr. 2011;94:1113–26.
Jee SH, He J, Appel LJ, Whelton PK, Suh I, Klag MJ. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2001;153:353–62.
Ricketts M-L, Boekschoten MV, Kreeft AJ, Hooiveld GJ, Moen CJ, Müller M, et al. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors. Mol Endocrinol. 2007;21:1603–16.
Hang D, Kværner AS, Ma W, Hu Y, Tabung FK, Nan H, et al. Coffee consumption and plasma biomarkers of metabolic and inflammatory pathways in US health professionals. Am J Clin Nutr. 2019;109:635–47.
Cornelis MC, van Dam RM. Habitual Coffee and Tea Consumption and Cardiometabolic Biomarkers in the UK Biobank: The Role of Beverage Types and Genetic Variation. J Nutr. 2020;150:2772–88.
Liu D, Li Z-H, Shen D, Zhang P-D, Song W-Q, Zhang W-T, et al. Association of sugar-sweetened, artificially sweetened, and unsweetened coffee consumption with all-cause and cause-specific mortality: a large prospective cohort study. Annals of internal medicine. 2022;175:909–17.
Acknowledgements
The authors thank the participants and staff of seventh and eighth periods (2016–2021) of KNHANES for their valuable contributions.
Funding
This work was supported by the National Research Foundation of Korea funded by the Korean government (grant number NRF–2021R1F1A1050847). The National Research Foundation of Korea had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
The authors’ responsibilities were as follows— Conceptualization, YJ and SC; formal analysis, SC; investigation, YJ and SC; data curation, YJ and SC; funding acquisition, YJ; writing—original draft, SC; writing—review and editing, YJ. All the authors have read and agreed to the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
The Institutional Review Board of KCDC provided formal ethics approval for KNHANES datasets, and each participant provided informed consent.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Choi, S., Je, Y. Association between coffee consumption and metabolic syndrome in Korean adults. Eur J Clin Nutr 78, 905–915 (2024). https://doi.org/10.1038/s41430-024-01478-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-024-01478-w